Table 2.

Success rates of central neuraxial block-aided ECV-discordant randomized trials.

Study	*Gestational age	Treatment (%)	Control (%)	RR (95% CI)
EPIDURAL
Schorr et al. [29]	>37 weeks	24/35 (68.6)	11/34 (32.4)	2.12 (1.24, 3.62)
Mancuso et al. [28]	>37 weeks	32/54 (59.3)	18/54 (33.3)	1.78 (1.15, 2.75)
Total		89	88	1.90 (1.38, 2.64)
SPINAL
Weiniger et al. [30]	>37 weeks	24/36 (66.7)	11/34 (32.4)	2.06 (1.25, 3.43)
Dugoff et al. [31]	38 weeks	22/50 (44.0)	22/52 (42.3)	1.04 (0.67, 1.62)
Delisle et al. [32]	Unknown	41/99 (41.4)	31/102 (30.4)	1.36 (0.94, 1.98)
Hollard [33]	>37 weeks	9/17 (52.9)	10/19 (52.6)	1.01 (0.54, 1.82)
Total		202	207	1.31 (1.04, 1.66)
⊥ CSE
Sullivan [34]	>36 weeks	22/48 (45.8)	18/47 (38.3)	1.19 (0.74, 1.92)
Overall Total		339	342	1.45 (1.21, 1.72)

*Gestational age when ECV was performed. ^⊥CSE combined spinal and epidural.